Inna Golovchikova

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
MOTIVATION New efforts to guide and prioritize the selection of cancer drug targets are urgently needed, as is evident by the slow development of novel anti-cancer agents and the narrow therapeutic index of existing drugs. Given these limitations, the current study was conducted to explore the classification features defining the therapeutic success that(More)
  • 1